Dáil Éireann Debate, Tuesday - 29 September 2015
470. Deputy Michael Healy-Rae asked the Minister for Health if the Health Products Regulatory Authority's duty of protection extends to protecting the patients who have been prescribed Roaccutane; and if he will make a statement on the matter. [33361/15]
View answer471. Deputy Michael Healy-Rae asked the Minister for Health the position in relation to safeguards to protect the general public with regard to concerns expressed about Roaccutane; and if he will make a statement on the matter. [33374/15]
View answerI propose to take Questions Nos. 470 and 471 together.
I refer the Deputy to my composite reply 19166/15 of 19 May and composite reply 26767/15 of 2 July both which provide a detailed reply to the questions asked by the Deputy.
